Achieve Life Sciences Inc (ACHV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -39,827 | -27,467 | -14,955 | -6,494 | -29,815 |
| Depreciation Amortization | 252 | 180 | 114 | 57 | 228 |
| Accounts payable and accrued liabilities | 1,332 | 393 | -68 | -245 | -1,042 |
| Other Working Capital | 2,301 | 895 | 724 | -670 | -772 |
| Other Operating Activity | 6,172 | 5,418 | 3,976 | 2,064 | 6,922 |
| Operating Cash Flow | $-29,770 | $-20,581 | $-10,209 | $-5,288 | $-24,479 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -21,580 | -33,297 | -46,568 | N/A | N/A |
| PPE Investments | N/A | N/A | N/A | N/A | -21 |
| Investing Cash Flow | $-21,580 | $-33,297 | $-46,568 | $N/A | $-21 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -18,109 | -18,109 | N/A | N/A | N/A |
| Common Stock Issued | 860 | N/A | N/A | N/A | 197 |
| Other Financing Activity | 65,776 | 65,954 | 55,957 | 56,110 | 15,081 |
| Financing Cash Flow | $48,527 | $47,845 | $55,957 | $56,110 | $15,278 |
| Exchange Rate Effect | N/A | 1 | N/A | N/A | -3 |
| Beginning Cash Position | 15,596 | 15,596 | 15,596 | 15,596 | 24,821 |
| End Cash Position | 12,773 | 9,564 | 14,776 | 66,418 | 15,596 |
| Net Cash Flow | $-2,823 | $-6,032 | $-820 | $50,822 | $-9,225 |
| Free Cash Flow | |||||
| Operating Cash Flow | -29,770 | -20,581 | -10,209 | -5,288 | -24,479 |
| Capital Expenditure | N/A | N/A | N/A | N/A | -21 |
| Free Cash Flow | -29,770 | -20,581 | -10,209 | -5,288 | -24,500 |